IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation
The arrangement includes global product mastering, and simplified access to IQVIA’s resources for data-driven decisions.
Drug Development
Repertoire and Lilly join hands on autoimmune disease therapies
Sensorion announces $71.9m reserved offering to expand gene therapy pipeline
FDA grants breakthrough status to Biogen’s litifilimab for CLE
FDA accepts Otsuka’s centanafadine application for ADHD treatment
Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies
Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline
FDA to review Eisai’s Leqembi Iqlik sBLA for Alzheimer’s
